{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:23:35Z","timestamp":1773829415233,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.oret.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:50:47Z","timestamp":1718326247000},"page":"1100-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma"],"prefix":"10.1016","volume":"8","author":[{"given":"Megan S.","family":"Steinkerchner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-2518","authenticated-orcid":false,"given":"Caleb D.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-4419","authenticated-orcid":false,"given":"Anne M.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-6026","authenticated-orcid":false,"given":"Frances","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos S.","family":"Gragoudas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0310-6129","authenticated-orcid":false,"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2024.06.004_bib1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.06.004_bib2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0161-6420(92)31900-1","article-title":"Intraocular recurrence of uveal melanoma after proton beam irradiation","volume":"99","author":"Gragoudas","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.06.004_bib3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay proton therapy center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2024.06.004_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajo.2003.12.032","article-title":"Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years\u2019 experience with beta-rays)","volume":"137","author":"Rouberol","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.brachy.2014.04.002","article-title":"(106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence","volume":"13","author":"Barker","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.oret.2024.06.004_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2014.01.026","article-title":"Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes","volume":"89","author":"Perez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2024.06.004_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2024.06.004_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brachy.2011.01.006","article-title":"A\u00a017-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective","volume":"10","author":"Leonard","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.oret.2024.06.004_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijrobp.2005.09.035","article-title":"Conservation treatment of the eye: conformal proton reirradiation for recurrent uveal melanoma","volume":"64","author":"Marucci","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2024.06.004_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2009.12.018","article-title":"Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation","volume":"79","author":"Marucci","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2024.06.004_bib12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ijrobp.2012.10.005","article-title":"Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences","volume":"85","author":"Caujolle","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2024.06.004_bib13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ajo.2014.07.013","article-title":"Salvage proton beam therapy in local recurrent uveal melanoma","volume":"158","author":"Riechardt","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","article-title":"Local recurrence after primary proton beam therapy in uveal melanoma: risk factors, retreatment approaches, and outcome","volume":"160","author":"Seibel","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2017.01.024","article-title":"Local failure after episcleral brachytherapy for posterior uveal melanoma: patterns, risk factors, and management","volume":"177","author":"Bellerive","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5114\/jcb.2019.82888","article-title":"Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review","volume":"11","author":"Tagliaferri","year":"2019","journal-title":"J\u00a0Contemp Brachytherapy"},{"key":"10.1016\/j.oret.2024.06.004_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajo.2016.12.022","article-title":"Repeat episcleral plaque brachytherapy: clinical outcomes in patients treated for locally recurrent posterior uveal melanoma","volume":"176","author":"King","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.oret.2022.05.006","article-title":"A\u00a0comparison of treatment outcomes after standard dose (70 Gy) versus reduced dose (50 Gy) proton radiation in patients with uveal melanoma","volume":"6","author":"Lane","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2024.06.004_bib19","series-title":"AJCC Cancer Staging Manual","first-page":"805","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2016"},{"key":"10.1016\/j.oret.2024.06.004_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bjo-2022-323133","article-title":"Survival of patients with recurrent uveal melanoma after treatment with radiation therapy","volume":"108","author":"Lane","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archopht.120.12.1665","article-title":"Evidence-based estimates of outcome in patients irradiated for intraocular melanoma","volume":"120","author":"Gragoudas","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2024.06.004_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0161-6420(87)33439-6","article-title":"Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation","volume":"94","author":"Seddon","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.06.004_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.06.004_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T07:17:13Z","timestamp":1730704633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653024002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2468653024002732"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2024.06.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}